Literature DB >> 31484733

Uncovering Structural and Molecular Dynamics of ESAT-6:β2M Interaction: Asp53 of Human β2-Microglobulin Is Critical for the ESAT-6:β2M Complexation.

Vishwanath Jha1,2, Nagender Rao Rameshwaram1, Sridhara Janardhan3, Rajeev Raman4, G Narahari Sastry3, Vartika Sharma5, Jasti Subba Rao6, Dhiraj Kumar5, Sangita Mukhopadhyay7.   

Abstract

ESAT-6 is a small secreted protein of Mycobacterium tuberculosis involved in the ESAT-6 secretion system (ESX-1)-mediated virulence and pathogenesis. The protein interacts with β2M, causing downregulation of MHC class I Ag presentation, which could be one of the mechanisms by which it favors increased survival of the bacilli inside the host. In an earlier study, we have shown that the C-terminal region of ESAT-6 is crucial for its interaction with β2M. However, the interface of β2M involved in interaction with ESAT-6 and detailed physicochemical changes associated with ESAT-6:β2M complexation are not fully defined. In this study, using computational and site-directed mutagenesis studies, we demonstrate the presence of strong noncovalent hydrophobic interactions between ESAT-6 and β2M in addition to the vital hydrogen bonding between the aspartate residue (Asp53) of β2M and methionine (Met93) of ESAT-6. Docking-based high-throughput virtual screening followed by 16-point screening on microscale thermophoresis resulted in the identification of two potent inhibitors (SM09 and SM15) that mask the critical Met93 residue of ESAT-6 that is required for ESAT-6:β2M interaction and could rescue cell surface expression of β2M and HLA in human macrophages as well as MHC class I Ag presentation suppressed by ESAT-6 in peritoneal macrophages isolated from C57BL/6 mice. Both SM09 and SM15 significantly inhibited intracellular survival of M. tuberculosis in human macrophages. Further, we characterized the physicochemical properties involved in the ESAT-6:β2M complexation, which may help in understanding host-pathogen interactions.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31484733     DOI: 10.4049/jimmunol.1700525

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.

Authors:  Sita Sirisha Madugula; Selvaraman Nagamani; Esther Jamir; Lipsa Priyadarsinee; G Narahari Sastry
Journal:  Mol Divers       Date:  2021-09-01       Impact factor: 2.943

2.  Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV.

Authors:  Himakshi Sarma; Esther Jamir; G Narahari Sastry
Journal:  J Mol Struct       Date:  2022-02-08       Impact factor: 3.841

3.  A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV.

Authors:  Himakshi Sarma; G Narahari Sastry
Journal:  ACS Omega       Date:  2022-08-17

4.  Mycobacterium tuberculosis Cell Wall Permeability Model Generation Using Chemoinformatics and Machine Learning Approaches.

Authors:  Selvaraman Nagamani; G Narahari Sastry
Journal:  ACS Omega       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.